Recon: FDA to reconsider Atara, Pierre Fabre drug after surprise rejection; Amazon to stock Ozempic at US kiosks

May 7, 2026


Euro Roundup: MedTech Europe seeks changes to proposed MDR revisions

Roundups

  

Search

RECENT PRESS RELEASES